tradingkey.logo

Privia Health Group Inc

PRVA

22.885USD

+0.235+1.04%
Fechamento 06/16, 16:00ETCotações atrasadas em 15 min
2.78BValor de mercado
193.12P/L TTM

Privia Health Group Inc

22.885

+0.235+1.04%
Mais detalhes de Privia Health Group Inc Empresa
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Informações da empresa
Código da empresaPRVA
Nome da EmpresaPrivia Health Group Inc
Data de listagemApr 29, 2021
Fundado em2016
CEOMr. Parth Mehrotra
Número de funcionários1140
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 29
Endereço950 N. Glebe Rd., Suite 700
CidadeARLINGTON
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal22203
Telefone15713668850
Sitehttps://www.priviahealth.com/
Código da empresaPRVA
Data de listagemApr 29, 2021
Fundado em2016
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
-1.09%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-14.94%
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
49.88K
+20.24%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+36.84%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+43.90%
Mr. Edward C. Fargis
Mr. Edward C. Fargis
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
--
--
Ms. Nancy G. Cocozza
Ms. Nancy G. Cocozza
Independent Director
Independent Director
--
--
Mr. David King
Mr. David King
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Shawn Morris, CPA
Mr. Shawn Morris, CPA
Director
Director
--
--
Mr. David Scott (Dave) Wichmann
Mr. David Scott (Dave) Wichmann
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
-1.09%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-14.94%
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
49.88K
+20.24%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+36.84%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+43.90%
Mr. Edward C. Fargis
Mr. Edward C. Fargis
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
FFS-patient care
1.15B
66.01%
Capitated revenue
212.99M
12.27%
Shared savings
179.20M
10.32%
FFS-administrative services
125.43M
7.22%
Care management fees
64.07M
3.69%
Other revenue
8.55M
0.49%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
FFS-patient care
1.15B
66.01%
Capitated revenue
212.99M
12.27%
Shared savings
179.20M
10.32%
FFS-administrative services
125.43M
7.22%
Care management fees
64.07M
3.69%
Other revenue
8.55M
0.49%
Distribuição de ações
Atualizado em: ter, 20 de mai
Atualizado em: ter, 20 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.81%
BlackRock Institutional Trust Company, N.A.
12.65%
Durable Capital Partners LP
9.42%
The Vanguard Group, Inc.
9.23%
Rubicon Founders, LLC
4.74%
Other
51.15%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.81%
BlackRock Institutional Trust Company, N.A.
12.65%
Durable Capital Partners LP
9.42%
The Vanguard Group, Inc.
9.23%
Rubicon Founders, LLC
4.74%
Other
51.15%
Tipos de investidores
Investidores
Proporção
Investment Advisor
54.12%
Investment Advisor/Hedge Fund
28.56%
Hedge Fund
12.36%
Individual Investor
6.71%
Research Firm
3.31%
Pension Fund
1.42%
Bank and Trust
0.38%
Sovereign Wealth Fund
0.06%
Venture Capital
0.04%
Participação acionária institucional
Atualizado em: ter, 4 de mar
Atualizado em: ter, 4 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
516
138.27M
113.98%
-7.29M
2024Q4
523
135.99M
112.85%
-22.61M
2024Q3
533
137.04M
114.53%
-19.89M
2024Q2
535
137.24M
115.06%
-22.76M
2024Q1
525
138.01M
116.30%
-17.09M
2023Q4
500
129.42M
109.89%
-22.91M
2023Q3
486
123.27M
105.26%
-25.19M
2023Q2
471
121.24M
104.92%
-8.36M
2023Q1
415
110.23M
95.73%
-8.00M
2022Q4
397
110.15M
96.45%
-94.54M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
15.78M
13.01%
+33.45K
+0.21%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
15.76M
12.99%
+241.25K
+1.55%
Dec 31, 2024
Durable Capital Partners LP
11.49M
9.47%
+378.25K
+3.40%
Dec 31, 2024
The Vanguard Group, Inc.
11.40M
9.4%
-421.82K
-3.57%
Dec 31, 2024
Rubicon Founders, LLC
5.77M
4.76%
--
--
Dec 31, 2024
Boehler (Adam)
5.32M
4.38%
+5.32M
--
Mar 25, 2024
Riverbridge Partners, LLC
5.82M
4.8%
+958.42K
+19.70%
Dec 31, 2024
State Street Global Advisors (US)
4.24M
3.5%
+82.10K
+1.97%
Dec 31, 2024
Principal Global Investors (Equity)
3.08M
2.54%
-174.39K
-5.36%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.41M
1.98%
-8.24K
-0.34%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
Global X HealthTech ETF
2.75%
SPDR S&P Health Care Services ETF
1.9%
Invesco S&P SmallCap Health Care ETF
1.62%
BNY Mellon Innovators ETF
1.09%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.07%
Langar Global HealthTech ETF
0.88%
First Trust Small Cap Growth AlphaDEX Fund
0.67%
Harbor Human Capital Factor US Small Cap ETF
0.58%
WisdomTree US SmallCap Quality Growth Fund
0.45%
iShares U.S. Healthcare Providers ETF
0.41%
Ver Mais
Global X HealthTech ETF
Proporção2.75%
SPDR S&P Health Care Services ETF
Proporção1.9%
Invesco S&P SmallCap Health Care ETF
Proporção1.62%
BNY Mellon Innovators ETF
Proporção1.09%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção1.07%
Langar Global HealthTech ETF
Proporção0.88%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.67%
Harbor Human Capital Factor US Small Cap ETF
Proporção0.58%
WisdomTree US SmallCap Quality Growth Fund
Proporção0.45%
iShares U.S. Healthcare Providers ETF
Proporção0.41%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI